Tomas Davor, Vucić Majda, Situm Mirna, Kruslin Bozo
Ljudevit Jurak Department of Pathology, Sestre Milosrdnice University Hospital, Zagreb, Croatia.
Arch Dermatol Res. 2008 Aug;300(7):393-5. doi: 10.1007/s00403-008-0848-z. Epub 2008 Apr 2.
Psoriasis is a chronic inflammatory skin disease characterized by exaggerated keratinocyte proliferation. Current opinion indicates that psoriasis is driven by T cell-mediated immune responses targeting keratinocytes. However, psoriasis cannot be explained solely on the basis of T-cell activation, and it is likely that an intrinsic alteration in epidermal keratinocytes plays a very important role in disease expression. Syndecans comprise a major family of cell surface heparan sulfate proteoglycans. Several studies indicate their role in adhesion, cell-extracellular matrix interactions, migration, keratinocyte proliferation and differentiation, inflammation, and wound healing. To determine the expression of syndecan-1 in psoriasis, skin samples from 29 patients with fully developed psoriasis and skin samples from 14 healthy volunteer persons with no personal or family history of psoriasis were immunohistochemically examined using monoclonal antibody against syndecan-1. The expression of syndecan-1 was analyzed in whole mount section of psoriatic and non-psoriatic skin biopsies under high magnification (400x). In addition, the intensity and topography of reaction in the cell, as well as localization of positive cells in the epidermis were evaluated. Strong syndecan-1 reactivity in epidermal cells in all non-psoriatic and psoriatic samples was observed. Statistical analysis showed no significant differences between two analyzed groups (P > 0.05). In normal skin syndecan-1 was expressed in full thickness of the epidermis. The strongest reaction was observed in membranes and intercellular junctions of spinous and granular layer while basal cells showed weaker expression that was confined to cytoplasm. In psoriatic skin syndecan-1 was expressed in the membrane and intercellular junction of cells located in thickened and elongated rete ridges of the epidermis. The strongest reaction was in basal and suprabasal layers and expression diminished through spinous layer. Cells in spinous layer lose syndecan-1 expression, which is opposite pattern to normal skin. Our results suggest that aberrant skin expression of syndecan-1 may be involved in the development of psoriasis.
银屑病是一种以角质形成细胞过度增殖为特征的慢性炎症性皮肤病。目前观点认为,银屑病是由针对角质形成细胞的T细胞介导的免疫反应所驱动。然而,银屑病不能仅基于T细胞活化来解释,表皮角质形成细胞的内在改变很可能在疾病表现中起非常重要的作用。Syndecans是细胞表面硫酸乙酰肝素蛋白聚糖的一个主要家族。多项研究表明它们在黏附、细胞与细胞外基质相互作用、迁移、角质形成细胞增殖与分化、炎症及伤口愈合中发挥作用。为确定syndecan-1在银屑病中的表达情况,使用抗syndecan-1单克隆抗体对29例银屑病病情完全发展的患者的皮肤样本以及14例无银屑病个人或家族史的健康志愿者的皮肤样本进行免疫组织化学检查。在高倍镜(400倍)下对银屑病和非银屑病皮肤活检组织的整装切片中syndecan-1的表达进行分析。此外,还评估了细胞内反应的强度和形态以及表皮中阳性细胞的定位。在所有非银屑病和银屑病样本的表皮细胞中均观察到强syndecan-1反应性。统计分析显示两个分析组之间无显著差异(P>0.05)。在正常皮肤中,syndecan-1在表皮全层表达。在棘层和颗粒层的细胞膜和细胞间连接处观察到最强反应,而基底细胞表达较弱,局限于细胞质。在银屑病皮肤中,syndecan-1在表皮增厚和延长的 rete嵴中细胞的细胞膜和细胞间连接处表达。最强反应在基底层和基底层上方,通过棘层表达减弱。棘层细胞失去syndecan-1表达,这与正常皮肤的模式相反。我们的结果表明,syndecan-1在皮肤中的异常表达可能参与了银屑病的发生发展。